13F
中

RIGL RIGEL PHARMACEUTICALS INC

2026Q1 · CUSIP 766559702 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
146
Δ holders QoQ
-38
Breadth percentile
Top 96%
Whale holders
89
Δ whales
-12
Inst. holding value
$428M
New positions
15
Closed positions
53
Price momentum (1Q)
-19.5%
Put / Call
2/3

Breadth history (34 quarters)

2024Q3: Δ+6 · h=90 2024Q4: Δ+27 · h=117 2025Q1: Δ+1 · h=118 2025Q2: Δ+6 · h=124 2025Q3: Δ+40 · h=164 2025Q4: Δ+20 · h=184 2026Q1: Δ-38 · h=146 2024Q3: holders=90 2024Q4: holders=117 2025Q1: holders=118 2025Q2: holders=124 2025Q3: holders=164 2025Q4: holders=184 2026Q1: holders=146 -40 -20 +0 +20 +40 81138194 24Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 6% -13.8% -32.2%
2024Q4 Top 19% -5.0% +87.8%

Options Sentiment

Put holders
2
QoQ: -1
Call holders
3
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
2.2
EPS (TTM)
$19.29
EPS YoY
+823.0%
Revenue (TTM)
$0.3B
Revenue YoY
+47.6%
Quarterly Revenue & EPS (4Y)
2022-06-30: $30M 2022-09-30: $22M 2022-12-31: $51M 2023-03-31: $26M 2023-06-30: $27M 2023-09-30: $28M 2023-12-31: $36M 2024-03-31: $30M 2024-06-30: $37M 2024-09-30: $55M 2024-12-31: $58M 2025-03-31: $53M 2025-06-30: $102M 2025-09-30: $69M 2025-12-31: $70M 2026-03-31: $59M 2023-06-30: EPS -0.38 2023-09-30: EPS -0.33 2023-12-31: EPS -0.65 2024-03-31: EPS -0.47 2024-06-30: EPS -0.06 2024-09-30: EPS 0.70 2024-12-31: EPS 0.82 2025-03-31: EPS 0.63 2025-06-30: EPS 3.28 2025-09-30: EPS 1.46 2025-12-31: EPS 14.11 2026-03-31: EPS 0.44 0M 51M 102M $M -0.72 7.40 15.52 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 7 2024-12-31: PE 21.82025-03-31: PE 9.52025-06-30: PE 7.32025-09-30: PE 6.82025-12-31: PE 1.82026-03-31: PE 1.5 1 12 23 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)